Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery ...

BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with Daiichi Sankyo (TSE: 4568). The collaboration will integrate ...

Crop pests cause substantial yield losses worldwide and pose persistent challenges to sustainable agriculture.

A new spatial transcriptomic technology captures RNA patterns without requiring expensive imaging ...

Environmental exposure to thousands of synthetic chemicals poses a growing challenge for public health, largely because their ...

On 4 February 2026, PharosAI announced it would use 10x Genomics’ Xenium spatial platform to convert archived NHS cancer ...

Discover how proteomics data analysis and bioinformatics tools enhance mass spectrometry workflows for robust findings.

According to Valuates Reports, The global market for AI in Biotechnology was valued at USD 1033 Million in the year 2024 and ...

Enhancing protein identification accuracy is vital for proteomics; this article explores key technologies and statistical methods involved.

A comprehensive single-cell atlas of AML uncovers regulatory networks and age-dependent molecular differences to advance the understanding of disease mechanisms and enable subtype-specific therapeutic ...

SANTA CLARA, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- OmicInsight Corporation, an innovator in ...

This proteomics-driven approach to drug discovery improves target validation and uncovers insights into undruggable proteins, ...